Page last updated: 2024-09-05

beta-solamarine and Stomach Neoplasms

beta-solamarine has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ao, S; Dong, B; Du, H; Fu, R; Hu, Y; Ji, J; Lv, G; Sun, Z; Wang, X; Zhang, L	1

Other Studies

1 other study(ies) available for beta-solamarine and Stomach Neoplasms

Article	Year
Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway. International journal of oncology, 2019, Volume: 54, Issue:5 Topics: Animals; Butadienes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Nitriles; RNA, Long Noncoding; Solanaceous Alkaloids; Stomach Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays	2019

Article

Year

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.

International journal of oncology, 2019, Volume: 54, Issue:5

Topics: Animals; Butadienes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Nitriles; RNA, Long Noncoding; Solanaceous Alkaloids; Stomach Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays

2019